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Abstract 
Unbiased genomic screening analyses have highlighted novel immunomodulatory properties 
of the active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D). However, clearer 
interpretation of the resulting gene expression data is limited by cell model specificity. The 
aim of the current study was to provide a broader perspective on common gene regulatory 
pathways associated with innate immune responses to 1,25(OH)2D, through systematic re-
interrogation of existing gene expression databases from multiple related monocyte models 
(the THP-1 monocytic cell line (THP-1), monocyte-derived dendritic cells (DCs), and 
monocytes). Vitamin D receptor (VDR) expression is common to multiple immune cell types, 
and thus pathway analysis of gene expression using data from multiple related models 
provides an inclusive perspective on the immunomodulatory impact of vitamin D. A 
bioinformatic workflow incorporating pathway analysis using PathVisio and WikiPathways 
was utilised to compare each set of gene expression data based on pathway level context. 
Using this strategy, pathways related to the TCA cycle, oxidative phosphorylation and ATP 
synthesis and metabolism were shown to significantly regulated by 1,25(OH)2D in each of 
the repository models (Z-scores 3.52 – 8.22). Common regulation by 1,25(OH)2D was also 
observed for pathways associated with apoptosis and the regulation of apoptosis (Z-scores 
2.49 – 3.81). In contrast to the primary culture DC and monocyte models, the THP-1 
myelomonocytic cell line showed strong regulation of pathways associated with cell 
proliferation and DNA replication (Z-scores 6.1 – 12.6). In short, data presented here support 
a fundamental role for active 1,25(OH)2D as a pivotal regulator of immunometabolism. 
247 Words 
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Introduction 
In recent years studies in vivo and in vitro have shown that vitamin D is able to influence 
biological responses that extend far beyond its classical effects on skeletal homeostasis. 
Prominent amongst these extra-skeletal effects is the interaction between vitamin D and the 
immune system, including regulation of both innate and adaptive immune responses (Adams 
and Hewison 2008; Hewison 2011; Wei and Christakos 2015). As a consequence of these 
observations, vitamin D-deficiency has been linked to increased risk of bacterial and viral 
infection (Lake and Adams 2011; Nnoaham and Clarke 2008), as well as inflammatory and 
autoimmune disease (Cantorna 2012; Jeffery, et al. 2016). The ability of supplementary or 
therapeutic vitamin D to prevent or improve these immune disorders is much less clear, and 
is the subject of randomized placebo control trials currently underway. Crucially, improved 
understanding of the mechanisms that underpin the immunomodulatory actions of vitamin D 
has greatly helped to improve the design and outcome of clinical trials. In particular, 
unbiased analysis of gene responses to vitamin D supplementation has uncovered 
previously unrecognised immune targets for vitamin D (Chun, et al. 2014; Liu, et al. 2006) 
that are now key markers of vitamin D function in supplementation trials. 
 
The initial observation linking vitamin D and immune function was detection of the nuclear 
vitamin D receptor (VDR) in lymphocytic and myeloid cells (Bhalla, et al. 1983; Mangelsdorf, 
et al. 1984), indicating that these cells are able to respond to the active form of vitamin D, 
1,25(OH)2D which binds with VDR. Further studies showed that cells from innate immune 
system such as monocytes/macrophages (Kreutz, et al. 1993) and dendritic cells (DC) 
(Hewison, et al. 2003) are also able to synthesise 1,25(OH)2D from the inactive precursor 
25-hydroxyvitamin D (25D), the main circulating form of vitamin D. As the principal effect of 
dietary vitamin D supplementation is to raise serum levels of 25D, the ability of monocytes 
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and DCs to convert 25D to 1,25(OH)2D provides a localised, autocrine, pathway by which 
enhanced 25D can influence both innate and adaptive immunity (Jeffery, et al. 2012; Liu et 
al. 2006). These observations placed monocytes and DCs at the centre of the 
immunomodulatory activity of vitamin D. Synthesis of 1,25(OH)2D by these cells has the 
potential to influence endogenous innate immune cell function in the form of enhanced 
antibacterial activity (Hewison 2011; Liu et al. 2006), and/or modulated antigen presentation 
(Hewison et al. 2003; Jeffery et al. 2012). Furthermore, 1,25(OH)2D generated by monocytes 
and/or DCs may also impact adaptive immune function by exert exogenous effects on T cells 
or B cells expressing VDR (Jeffery et al. 2012). Despite this, our understanding of the 
broader impact of vitamin D on cells from the innate immune system such as monocytes, 
macrophages and DCs remains far from clear.  
 
Recent genome-wide expression studies using a monocyte-derived DC model highlighted 
the potential role of pathways associated with glucose metabolism, the TCA cycle and 
oxidative phosphorylation in mediating the effects of 1,25(OH)2D in promoting a tolerogenic 
DC phenotype (Ferreira, et al. 2015). The aim of the current study was to provide a broader 
analysis of monocyte/DC responses to 1,25(OH)2D using existing gene expression 
repositories for multiple models of innate immune function. A meta-analysis of various 
datasets has been performed using an integrative workflow of open-source bioinformatics 
tools in order to give a biological context to the genes that are significantly modulated by 
1,25(OH)2D. Finally, a comparison between the immune cell types selected has been 
applied to highlight the common biological processes that are altered by vitamin D.  
 
Materials & Methods 
Workflow overview 
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A workflow was developed that utilises and integrates gene expression data from public 
repositories and places them in a biological context. Supplemental Figure 1 illustrates step 
by step the different tools and methods used in the analysis workflow. The first procedure 
consisted of open and free modules in ArrayAnalysis to i) perform a data quality check, ii) 
normalize the raw transcriptomic data and iii) perform a statistical analysis to obtain the 
parameters that show gene expression changes. The processed datasets were then applied 
to PathVisio v. 3.2.4 software (Kutmon, et al. 2015; van Iersel, et al. 2008) in order to 
perform statistical analyses that highlight the biological processes significantly altered as a 
consequence of gene expression changes and to visualize them in pathway diagrams from 
the WikiPathways pathway repository downloaded January 2017 (Kutmon, et al. 2016). 
Comparison of the pathways shown to be significantly altered between the different cell 
types using PathVisio and WikiPathways was also represented by heat maps diagrams. In 
another approach, genes shown to be regulated by 1,25(OH)2D in all three cell models were 
used to identify enriched biological processes by Gene Ontology (GO) analysis and the 
results were visualized in biological networks using ClueGO v 2.3.3 (Bindea, et al. 2009), an 
app of Cytoscape 3.4.0 (Smoot, et al. 2011) (Supplemental Figure 1). This workflow is 
designed in a user friendly fashion that does not require programming skills. In order to 
reproduce this workflow, it is recommended to use the latest versions of designated 
software. Furthermore, it is also important that gene annotation database and pathways 
repositories used in the analysis are regularly updated. 
 
Transcriptomic datasets 
Publically available transcriptomic data sets for 1,25(OH)2D-treated monocytes and dendritic 
cells (DC) were selected from ArrayExpress (https://www.ebi.ac.uk/arrayexpress/, 
(Kolesnikov, et al. 2015)) and Gene Expression Omnibus (GEO, http://ncbi.nlm.nih.gov/geo/, 
Page 5 of 40
6 
 
(Barrett and Edgar 2006)). Selection criteria were based on gene expression studies 
performed in human cells including monocytic cell lines, monocytes and monocyte-derived 
DCs treated with 1,25(OH)2D: THP-1 cells (GSE52819 (Verway, et al. 2013)), dendritic cells 
(GSE13762 (Széles, et al. 2009)) and human monocytes (GSE56490 (Ferreira et al. 2015)). 
The selection of the three studies was based on experimental design and quality control 
analysis of the raw data. In all studies data were derived from human immune cells treated 
with 1,25(OH)2D, or from control (vehicle-treated) cells (Supplemental Table 1). In addition 
to the three cell models outlined above, preliminary analyses were also carried out using 
other 1,25(OH)2D-treated cell data repositories: THP-1 cells (GSE60102 (Nurminen, et al. 
2015)) and human monocytes (GSE46268 (Wheelwright, et al. 2014)). In addition the data 
for GSE13762 (Széles, et al. 2009) included both immature and mature DC, and both these 
models were include in the preliminary analysis.  Finally, as a negative control, the 
preliminary pathway analysis included a 1,25(OH)2D-treated B cell dataset (GSE22523 
(Lisse, et al. 2011). Because of missing raw data, incomplete gene annotation, 
incompatibility with ArrayAnalysis, and non-monocyte origin, some data from the preliminary 
analysis were not included in the main analysis of this study, but relevant findings related to 
the data were addressed in Results.  
  
Pre-processing raw data and statistical data analysis in ArrayAnalysis 
Unprocessed transcriptomics data were collected from the repositories and processed using 
the on-line workflow of ArrayAnalysis performed in January 2017 
(https://www.arrayanalysis.org (Eijssen, et al. 2013)) to obtain quality control reports, 
normalized data and perform statistical analysis. The workflow uses an R script as a core 
module with functions from several Bioconductor libraries. Quality control showed that there 
was no need to exclude any samples in the three selected transcriptomic datasets (data not 
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shown). Depending on the microarray technology used the normalization algorithm was 
selected. RMA method was used to normalize GSE52819 (Verway et al. 2013) and 
GSE56490 (Ferreira et al. 2015). GC-RMA method was applied to GSE13762 (Szeles et al. 
2009). Statistical analysis of the normalized data to determine genes that are significantly 
altered (up/down-regulated), was carried out with a second module from ArrayAnalysis 
including the moderated t-test from the R/Bioconductor package limma (Ritchie, et al. 2009). 
The output is a table with the expression parameters for each gene showing fold change 
(FC), in a log scale) after 1,25(OH)2D treatment and the significance of changes by the 
Benjamini-Hochberg adjusted p-value. Based on statistical gene expression parameters the 
significantly up/down-regulated genes were identified using the criteria: absolute log2FC => 
0.26 and adjusted p value < 0.05. The average expression (AE) was used to filter out lowly 
expressed genes and the cut-off was specific for each dataset based on the density plot of 
the intensities after normalization: THP-1 AE > 4.25; immature DC AE > 3.86; and 
monocytes AE > 9.5 (Table 1). 
 
Pathway statistics and analysis in PathVisio 
PathVisio v. 3.2.4 (Kutmon, et al. 2015; van Iersel, et al. 2008), an open-source pathway 
creation and analysis tool, was used to contextualize significantly altered genes, and altered 
biological processes were visualised using the biological pathway repository WikiPathways 
(Kutmon, et al. 2016). Utilizing the BridgeDb identifier mapping feature released on 18 
October 2016 (http://www.bridgedb.org/) (van Iersel, et al. 2010), PathVisio recognizes 
genes (probe) identifiers from the most used databases and microarray platforms such as 
NCBI and Affymetrix. This identifier mapping database (Homo sapiens Derby Ensembl 85 
gene database) enables linking of statistical values from analyzed data to the corresponding 
gene boxes in the pathway diagrams of WikiPathways. In the analysis, the curated human 
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pathways collection (released April 2017, http://data.wikipathways.org/20170410/gpml/) of 
WikiPathways was used. For pathway analysis, a criterion is chosen to select genes that are 
significantly altered within each dataset based on the expression difference parameter of fold 
change (on log2 scale) and the significance of that change represented as the adjusted p 
value (<0.05). PathVisio performs an overrepresentation analysis taking into account all 
genes measured (N), genes that satisfy the criterion (R), genes measured in the experiment 
that are present in the pathway (n) and genes in the pathway measured in the experiment 
that satisfy the criteria (r): 
Z	Score = (
 − 
)
()(1 − )(1 −  − 1 − 1)
 
The Z-score is used to measure how significantly a subset of genes is altered in a certain 
pathway compared to the complete dataset. In our analysis, biological pathways that have a 
Z-score equal to or above 1.96 are considered significantly altered. The function heatmap.2 
from the R library gplots (v.3.0.1) was used to create a heatmap that compared and 
hierarchically clustered pathways for each of the datasets based on Z-scores. 
 
GO analysis with ClueGO in Cytoscape 
GO analysis of the in common significantly altered genes (absolute log2FC >= 0.26 and 
adjusted p value < 0.05) in the three types of immune cells was performed to identify and 
visualize which GO biological process terms were significantly overrepresented. Within the 
commonly used open-source network analysis tool Cytoscape v. 3.4 (Smoot et al. 2011), the 
ClueGO app v 2.3.3 performs GO analysis to group a set of genes in GO terms minimizing 
redundancy and display their relationship in a network. Connections between the GO nodes 
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containing a common sub-set of genes were calculated with kappa statistics based on the 
correlated genes that are grouped. 
 
Results 
Differentially expressed genes in 1,25(OH)2D-treated THP1 cells, dendritic cells and 
monocytes 
A preliminary pathway analysis of multiple THP-1, monocyte and DC datasets revealed 
common regulation of several key cell pathways by 1,25(OH)2D in cells from the myeloid 
lineage: electron transport, oxidative phosphorylation, the TCA cycle, glycolysis and 
gluconeogenesis, and apoptosis. By contrast, the non-myeloid B cell gene expression 
dataset showed no similarity with the myeloid effects of 1,25(OH)2D, underlining the lineage-
specific effects of 1,25(OH)2D (Supplemental Figure 2). From this initial pathway analysis it 
was also interesting to note that 1,25(OH)2D regulation of pathways associated with the cell 
cycle and cell proliferation were only observed in the myeloid leukemic cell line THP-1, and 
not the other non-neoplastic primary cell models used in the study (Supplemental Figure 
2). Because of incomplete raw data or gene annotation, or incompatibility with ArrayAnalysis, 
further, more detailed, pathway analysis was restricted to raw datasets for GSE52819, 
GSE13762, GSE56490. 
 
Pathway analysis reveals altered biological processes based on molecular changes in 
1,25(OH)2D-treated immune cells 
Pathway overrepresentation analysis performed on immune cell datasets GSE52819, 
GSE13762, and GSE56490 generated a list of biological processes regulated by 
1,25(OH)2D in each of the three different innate immune cell models. For each cell type the 
significantly altered pathways were selected and their Z-scores plotted and clustered in a 
Page 9 of 40
10 
 
heatmap (Figure 1) showing Z-score comparisons for major affected pathways between the 
three cell models. Data indicate that 1,25(OH)2D-regulated pathways were either cell-specific 
or common to all three models. Pathways related to DNA replication, the cell cycle, and 
cancer (retinoblastoma) showed high Z-scores, and were more strongly regulated by 
1,25(OH)2D in THP-1 cells, consistent with the proliferative leukemic nature of this cell line 
(25). By contrast, primary cells (DCs and monocytes) showed stronger 1,25(OH)2D-
regulation of pathways associated with glycolysis/gluconeogenesis and the apoptosis-related 
network due to altered Notch3 in ovarian cancer pathway relative to THP-1 cells, albeit at 
lower Z-scores than observed for THP-1-specific pathways. Pathways associated with 
apoptosis and apoptosis modulation and signalling also showed lower Z-scores, but were 
equally induced by 1,25(OH)2D in THP-1 cells, DCs and monocytes. The highest Z-score for 
1,25(OH)2D-regulated pathways common to all three cell models was for pathways related to 
the TCA cycle, oxidative phosphorylation and the electron transport chain.  
 
GO analysis shows metabolic, immunological and apoptotic processes altered by 
1,25D in THP-1 cells, dendritic cells and monocytes 
ArrayAnalysis processing of GSE52819, GSE13762, GSE56490 datasets was carried out to 
define the number of genes measured and number of genes significantly regulated by 
1,25(OH)2D in each of the three cell models (Table 1). Further analysis of these data 
showed that a total of 230 genes were significantly regulated by 1,25(OH)2D in all three cell 
models (Figure 2), and these genes were selected for subsequent GO analysis. 
 
GO analysis using the list of 230 commonly altered genes was carried out using ClueGO in 
Cytoscape to display networks of overrepresented biological processes associated with this 
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list. A total of 39 groups of GO terms resulted in the identification of three broad sub-
networks common to each of the cell models (Figure 3 and Supplemental Figure 3A-3B). 
 
The first of these networks was associated with bioenergetic GO-terms including the electron 
transport chain (GO:22904), oxidation-regulation process (GO:55114), oxidative 
phosphorylation (GO:6119), tricarboxylic acid cycle (GO:6099) and canonical glycolysis 
(GO:61621) (Figure 3). A second sub-network was based on immunological GO-terms such 
as responses to molecules of bacterial origin (GO:2237), cytokine production (GO:1816), 
inflammatory response (GO:6954) and myeloid cell differentiation (GO:30099) 
(Supplemental Figure 3A). The final network identified that groups of apoptotic processes 
such as intrinsic apoptotic signaling (GO:97193) and negative regulation of apoptotic 
signaling (GO:2001234) (Supplemental Figure 3B). 
 
Visualization of 1,25(OH)2D induced changes in gene expression in THP-1 cells, DCs 
and monocytes on altered metabolic pathways  
Pathways related to ATP metabolism showed high Z-scores (>1.96), indicating strong 
regulation by 1,25(OH)2D (Figure 2). To investigate the significant changes in gene 
expression in more depth the effect of 1,25(OH)2D on gene expression was visualized on the 
altered metabolic pathways discovered with pathway analysis, i.e., electron transport chain, 
oxidative phoshorylation and TCA cycle and glycolysis.  
 
1,25(OH)2D and the electron transport chain 
In the human electron transport chain pathway (Waagmeester et al 2017 
http://wikipathways.org/index.php/Pathway:WP111) significantly up-regulated or down-
regulated genes (adj. p-value < 0.05) in the three immune cells treated with 1,25(OH)2D 
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compared to untreated cells were collectively visualized. Overall, the electron transport chain 
was activated by 1,25(OH)2D in the three immune cells. Biological data in Figure 4 shows in 
all three cell types a significant increase in expression by 1,25(OH)2D of genes associated 
with electron transport chain complexes I (NDUFA2, NDUFA3, NDUFA8, NDUFB9, 
NDUFA10, NDUFB5, NDUFAB1, NDUFS3, NDUFV1, NDUFS1), complex II (SDHB), 
complex III (UQRC1-2), complex IV (COX4l1, COX5A) and complex V (ATP5A1, ATP5B, 
ATP5C1, ATP5G1, ATP5L). Interestingly, the gene expression of the uncoupling protein 2 
(UCP2) is significantly (adj. p-value < 0.05) down-regulated in THP-1 cells and monocytes 
by 1,25(OH)2D, but unchanged in dendritic cells. 
 
1,25(OH)2D and oxidative phosphorylation  
In the oxidative phosphorylation pathway (Dalquist et al 2016 
http://wikipathways.org/index.php/Pathway:WP623) all significantly changed genes were up-
regulated, demonstrating that this process is activated by 1,25(OH)2D in THP-1 cells, DCs 
and monocytes. Biological data in Figure 5 shows that specifically genes related to ATP 
synthase (ATPG3, ATP5G1, ATP5B, ATP5G1, ATP5A1, ATP5L) and nicotinamide 
nucleotide transhydrogenase (NDUFA3, NDUFS3, NDUFV1, NDUFA10, NDUFA8, NUDFB9 
NDUFS1, NDUFB5, NDUFAB1, NDUFA2) are significantly (adj. p-value < 0.05) up-regulated 
by 1,25(OH)2D in each of the cell models. 
 
1,25(OH)2D and the TCA cycle and glycolysis  
In the TCA cycle (Dalquist et al 2016 http://wikipathways.org/index.php/Pathway:WP78), the 
process that produces energy by oxidation of acetyl-CoA, 1,25(OH)2D up-regulates genes 
involved in the conversion of acetyl-CoA in carbohydrate and chemical energy. 1,25(OH)2D 
increased the expression of ACO2, IDH3, IDH4B, DLD, SUCLG1, SDHB and MDH2 and 
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only the expression of IDH2, which functions in the opposite direction of the cycle, was 
significantly (adj. p-value < 0.05) down-regulated (Figure 6). Glucose metabolism was also 
affected by 1,25(OH)2D, with enzymes such as HK2, PFKM and FBP1 being significantly 
(adj. p-value < 0.05) up-regulated after treatment (Supplemental Figure 4).  
 
1,25(OH)2D and cell proliferation 
Analysis of both THP-1 cell datasets (18, 19) revealed that 1,25(OH)2D had a significant 
effect on genes associated with the cell cycle (Conklin et al 2017 
https://www.wikipathways.org/instance/WP179_r93002)(Figure 7A). This included 
suppression of complexes involved in phase transitions and checkpoint signalling such as 
BUB1/BUB3, p34cdc2/cyclin B, Chk1/Chk2, and cell cyclin-dependent kinases (CDKs) such 
as CDK1, CDK2, and associated cyclins A1, A2, B1, B2 and E1, E2. THP-1 cells treated with 
1,25(OH)2D also showed decreased expression of genes associated with DNA replication 
(Koren et al 2017 https://www.wikipathways.org/instance/WP466_r94886)(Figure 7B). This 
included suppression of subunits of the maintenance protein complex (MCM), needed to 
initiate and elongate the replication fork in the DNA replication. 1,25(OH)2D also suppressed 
expression of genes that participate in progression of the cell cycle such as components of 
the assembly of the pre-replicative complex. This includes subunits of the component of the 
origin recognition complex (ORC): ORCL 1, 3 and 6. Genes that participate in the assembly 
of pre-replicative DNA complexes were also down-regulated by 1,25(OH)2D. These include: 
CDC6, and CDT1/GMNN complex. Finally, components of the DNA polymerase (POLa2, 
POLa, POLe2), primase (PRIM1, PRIM2) and subunits of the replication factor C (RFC1-5) 
were also down-regulated by 1,25(OH)2D in THP-1 cells (Supplemental Figure 5A-B). In 
contrast to effects in leukemic THP-1 cells, pathways associated with cell proliferation and 
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cell cycling were unaffected by 1,25(OH)2D in primary cultures of monocytes and dendritic 
cells (Supplemental Figure 2). 
 
 
1,25(OH)2D and apoptosis  
In the GO analysis, a network that relates apoptosis GO terms revealed three GO core 
groups: 1) negative regulation of apoptotic signaling; 2) intrinsic apoptotic signalling; 3) 
regulation of intrinsic apoptotic signaling pathway (Supplemental Figure 3B). These groups 
include genes that were up-regulated by 1,25(OH)2D in all three cells types such as: 
NDUFS3, TNFSF10, TRAP1, YBX3, NCK2, CEBPB, FXN, CYCS and NCK2. Conversely, 
CD74, DAPK1, ITGAV and FNIP2 were down-regulated by 1,25(OH)2D. Biological data in 
Supplemental Figures 6A and 6B show significant effects of 1,25(OH)2D on pathways 
associated with apoptosis. The receptor TNFTSF10D that participates negatively in 
apoptosis is up-regulated by 1,25(OH)2D in all three cell types, whilst the family of apoptotic 
caspases (2,3,4,6 and 7) and the apoptotic peptidase activating factor 1 (APAF1) are 
suppressed. Finally, it is interesting to note that JAK2 and MAP3K5 are down-regulated by 
1,25(OH)2D in THP-1 cells but up-regulated in DCs and monocytes.  
 
Discussion  
Bioinformatics, or applying informatics to study biology, seeks to provide an unbiased and 
statistically robust insight into the molecular mechanisms that impact human health and 
disease. Large-scale projects such as the Human Genome Project (Roberts, et al. 2001) and 
ENCODE (Consortium, et al. 2007) have provided access to expansive repositories of data 
that have greatly helped to shed light on genomic function. However, utilisation of these data 
repositories to answer specific biological questions remains limited. This is particularly true 
for studies of vitamin D, despite detailed genome-wide analysis of VDR-chromatin 
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interactions (Pike, et al. 2017). In most cases, analysis of the genomic responses to 
1,25(OH)2D-VDR complexes has been cell-specific, incorporating both classical calciotropic 
(Meyer, et al. 2014), and extra-skeletal (Neme, et al. 2016) effects of vitamin D. Recently, a 
more integrated approach to the bioinformatic interrogation of 1,25(OH)2D-VDR datasets has 
been described, utilising VDR chromatin immunoprecipitation-sequencing (ChIP-Seq) 
datasets with National Human Genome Research Institute (NHGRI) Genome-Wide 
Association Study (GWAS) Single Nucleotide Polymorphism (SNP) datasets (Singh 2017). 
This strategy of combining publicly available datasets presents a distinct set of challenges, 
notably in establishing statistical rigour and appropriate analytical workflows, but 
nevertheless provides a novel perspective on the role of vitamin D and the VDR in human 
health. Notably, integration of ChIP-seq-GWAS datasets emphasized an important role for 
VDR in regulating of target genes associated with immunomodulation (Singh 2017). The 
current study proposes an alternative bioinformatic approach to further interrogate the 
immunomodulatory function of 1,25(OH)2D-VDR. Utilising pathway analysis workflows to 
assess multiple RNA expression datasets for monocyte-derived cell models allowed to the 
identification of common cellular pathways that are regulated by 1,25(OH)2D, revealing an 
important new immunometabolic function for vitamin D. The analysis pipeline described here 
offers an alternative statistical approach to conventional software packages. The most 
notable advantage of the workflow presented here is that it is open source and user-friendly 
for the bioscience community, and enables reproducible and straightforward methodology 
that can process data from different gene expression analysis platforms. 
 
Transcriptomic analysis of gene-regulatory responses has played a pivotal role in defining 
the innate immune functions of vitamin D (Chun et al. 2014). Notable studies have utilized 
specific monocyte (Liu et al. 2006), and dendritic cell (Ferreira et al. 2015) models to identify 
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previously unrecognized molecular targets for active 1,25(OH)2D, which have, in turn, 
revealed antibacterial (Adams, et al. 2009; Bacchetta, et al. 2014; Chun, et al. 2015), and 
metabolic regulatory (Vanherwegen, et al. 2017) functions for vitamin D in these cells. 
Collation of data from these different studies provides an alternative strategy for analysis of 
the immunomodulatory function of vitamin D, by incorporating groups of regulated genes into 
cellular pathway analyses. Using this strategy it was possible to identify common cellular 
processes that are regulated by 1,25(OH)2D, as well as those that are more cell lineage-
specific. The major advantage of this workflow is that it contextualizes the experimental data 
at the biological process level using interactive pathways. Based on  criteria, the pathway 
statistics approach of PathVisio defines the genes that are significantly altered in the dataset 
and highlights the pathways of the WikiPathways repository that are altered after treatment 
with 1,25(OH)2D. In our pathway analysis we used the manually curated and up-to-date 
human pathway collection of WikiPathways containing a broad spectrum of biological 
processes, including well-described metabolic processes as well as signalling and gene 
regulatory processes. Pathway analysis not only highlights the altered biological processes 
based on changes in gene expression but it enables the investigation of the relationship 
between genes and different datasets in great detail. This makes pathway analysis a 
suitable approach for an integrative and in depth analysis of large-scale transcriptomic data.  
 
The most striking observation from the current analysis is that in all three cell models 
1,25(OH)2D is strongly associated with changes in cellular metabolism, oxidative 
phosphorylation and energy generation. Oxidative phosphorylation has been shown to play 
an important role in promoting a tolerogenic phenotype in immune cells (Michalek, et al. 
2011; Vats, et al. 2006). Previous studies have reported effects of 1,25(OH)2D on 
mitochondrial functionality and physiology, and pathways related to glucose metabolism in 
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monocyte-derived DCs (Ferreira et al. 2015). In a similar fashion, serum 25(OH)D status has 
been linked to markers of bioenergetic pathways in human peripheral blood mononuclear 
cells (Calton, et al. 2016), and active 1,25(OH)2D has been shown to increase production of 
ATP and ROS, as well as altering mitochondrial functionality and morphology by increasing 
its membrane potential and total mass of mitochondria in differentiating monocytes (Ferreira 
et al. 2015). It was therefore notable in the current study that the most significantly altered 
pathways common to all three innate immune cell types were those associated with 
mitochondrial function: TCA cycle, electron transport chain and oxidative phosphorylation. 
Collectively these observations underline an important role for 1,25(OH)2D as a positive 
regulator of mitochondrial metabolism and bioenergetic pathways in immune cells. 
Interestingly, this effect of 1,25(OH)2D appears to be consistent not only across the three 
myeloid cell models studied in detail in Figure 1, but is also observed within different DC 
sub-types. In the current study we chose an immature DC (iDC) model which focused purely 
on the effect of 1,25(OH)2D, although this was for a longer time period (5 days) than the 
other models. Nevertheless, further analysis showed that the pathway effects of 1,25(OH)2D 
on iDC over 5 days were similar to those observed in immune-activated mature DC (mDC) 
treated with 1,25(OH)2D for 12 hours (Supplemental Figure 2). 
 
Pathways associated with glycolysis and gluconeogenesis, such as the TCA cycle, were 
also significantly regulated by 1,25(OH)2D in all three cell types studied. Catabolism of 
glucose leads to the formation of pyruvate, a biomolecule that is then metabolized in the 
TCA cycle. At present, relatively little is known about the impact of vitamin D on the TCA 
cycle, other than clinical studies showing association between vitamin D deficiency and 
dysregulation of glucose metabolism like diabetes (Seida, et al. 2014). The present study 
demonstrates that several genes involved in the glucose metabolism are significantly 
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regulated by vitamin D (Supplemental Figure 4). Comparison of the THP-1, DC, and 
monocyte datasets showed that genes for enzymes such as hexokinase, 
phosphofructokinase and fructose-bisphosphatase are commonly up-regulated after 
1,25(OH)2D treatment. In contrast to oxidative phosphorylation and electron transport, the 
glycolysis/gluconeogenesis effects of 1,25(OH)2D were less consistent with some genes 
showing opposite patterns of regulation in different cell types. It is nevertheless clear that the 
regulation of glucose metabolism is a key facet of 1,25(OH)2D regulation of myeloid cells.  
 
Besides common targets for vitamin D in innate immune cells, analysis of multiple 
repositories also highlighted pathways that were cell model-specific. In THP-1 cells only, 
1,25(OH)2D potently regulated genes involved in progression of cell cycle and DNA 
replication, consistent with the neoplastic origin of these cells. The pathways with high Z-
score include Retinoblastoma in cancer, G1 to S cell cycle control, DNA replication and cell 
cycle, are similar to those reported previously for prostate cancer cells treated with 
1,25(OH)2D (Kutmon, et al. 2015a). This suggests that, in addition to its common metabolic 
innate immune targets, 1,25(OH)2D also has common antiproliferative targets in neoplastic 
cell types, including suppression of key proteins that participate in progression of the cell 
cycle and regulation of DNA replication (Kriebitzsch, et al. 2009). Interestingly, pathway 
analysis of 1,25(OH)2D in prostate cancer cells (Kutmon et al. 2015a) did not reveal any 
significant regulation of the metabolic pathways as identified for monocytes and DCs in the 
current study. Thus, in the same way that suppression of cell cycle/DNA replication genes 
appears to be a cancer cell-specific effect of 1,25(OH)2D, genes associated with oxidative 
phosphorylation and energy metabolism appear to be innate immune cell-specific. Previous 
studies using THP-1 cells have also included analysis of the temporal variations in response 
to treatment with 1,25(OH)2D (Seuter, et al. 2016). The datasets in this particular study did 
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not conform to requirements for the comparative pathway analysis used in our current study. 
However, we were able to carry out a preliminary pathway analysis of these data 
(Supplemental Figure 7). Here it was notable that metabolic and cell cycle effects of 
1,25(OH)2D were only observed after 24 hours of treatment, suggesting that pathway 
regulation by vitamin D is highly time-dependent. 
 
The third major group of pathways shown to be regulated by 1,25(OH)2D in THP-1, 
monocytes and DCs were those associated with programmed cell death (apoptosis). 
Previous studies have reported pro-apoptotic effects of 1,25(OH)2D in primary cultures of 
monocytes, with this effect being mediated via interference with CD40 responses (Almerighi, 
et al. 2009). Conversely, in the HL-60 leukemic cell line 1,25(OH)2D was reported to promote 
resistance to apoptosis (Mosieniak, et al. 2006). Furthermore, studies from our group have 
shown that antisense knockdown of VDR in another leukemic cell line, U937, promoted cell 
apoptosis (Hewison, et al. 1996). Data from the current study further support a role for 
1,25(OH)2D in regulating apoptosis of innate immune cells: common genes in the three 
datasets compared are commonly up-regulated (TNFTSF10D) and down-regulated 
(caspases family proteins and APAF1). 
 
Conclusions 
Understanding the entire set of results of high-throughput  gene expression studies has often 
been challenging, caused by the complicated process of data analysis, and the limited 
biological interpretation that could be extracted from the large datasets generated through 
bench experiments. As a consequence, genome-wide analyses have tended to focus on 
changes in expression for specific genes (Chun et al. 2014; Liu et al. 2006), or small groups 
of genes associated with a specific pathway (Ferreira et al. 2015). The aim of the current 
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study was to provide, for the first time, an unbiased analysis of the function of vitamin D in 
immune cells at a broader pathway level. Our resulting data demonstrate the added value of 
implementing a workflow with different bioinformatic tools that allows us to analyze gene 
expression data in a rapid, automated, and reproducible fashion, to highlight pathways that 
are significantly altered by 1,25(OH)2D. It is possible to visualize and further interrogate 
these biological diagrams to provide a detailed description of the molecular effects of 
1,25(OH)2D in different types of immune cells. Finally, comparison of different datasets has 
allowed us to identify pathways, notably those associated with cell metabolism, that are 
common to multiple different types of innate immune cells. This approach provides new 
insights into the immunomodulatory actions of vitamin D, but also has important implications 
for the many other physiological responses linked to vitamin D in recent studies. 
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Legends to figures and tables 
 
Figure 1. Common altered pathways in 1,25(OH)2D-treated THP-1, DCs and 
monocytes. Heat map representing Z-scores for pathways significantly altered by 
1,25(OH)2D after performing a pathway analysis on datasets for THP-1, DCs and monocytes 
treated with 1,25(OH)2D. Z-scores >1.96 indicate that more genes are significantly altered in 
this pathway compared to the complete dataset.  
 
Figure 2. 1,25(OH)2D-regulated genes in THP-1 cells, DCs and monocytes. Venn 
diagrams showing numbers of common and cell-specific genes regulated by 1,25(OH)2D in 
THP-1 cells, DCs and monocytes. Genes with an absolute log2 fold change > 0.26 and 
adjusted p-value < 0.05 were considered as regulated. 
 
Figure 3. ClueGO Gene ontology analysis of common 1,25(OH)2D-regulated 
bioenergetics genes in THP-1 cells, DCs and monocytes. Cytoscape analysis showing 
overrepresented bioenergetic pathways for 1,25(OH)2D-treated THP-1 cells, DCs and 
monocytes. Colours represent the GO group, each node is a GO biological process and the 
edges shows the connectivity between each node based on the connection of the genes that 
contain. The size of the nodes depends on the amount of genes that are grouped. Nodes 
with no connections are coloured in grey. 
 
Figure 4. Effect of 1,25(OH)2D on genes associated with the electron transport chain. 
Visualization of changes in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs 
and monocytes. Log2 fold changes are shown as a gradient from blue (downregulated) to 
red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are shown in green. 
 
Figure 5. Effect of 1,25(OH)2D on genes associated with oxidative phosphorylation. 
Visualization of changes in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs 
and monocytes. Log2 fold changes are shown as a gradient from blue (downregulated) to 
red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are shown in green. 
 
Figure 6. Effect of 1,25(OH)2D on genes associated with the TCA cycle. Visualization of 
changes in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs and monocytes. 
Log2 fold changes are shown as a gradient from blue (downregulated) to red (upregulated) 
over white (unchanged). Adjusted p-values < 0.05 are shown in green. 
 
Figure 7. Effect of 1,25(OH)2D on the expression of genes associated with cell 
proliferation in THP-1 cells. WikiPathways representation of A) cell cycle; B) DNA 
replication pathways. Visualization of changes in gene expression after 1,25(OH)2D 
treatment in THP-1 cells. Log2 fold changes are shown as a gradient from blue 
(downregulated) to red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are 
shown in green. 
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Supplemental Figure 1. Overview of the analytical tools included in the workflow. Raw 
data were normalised and statistically analysed using ArrayAnalysis. Pathway analysis of 
normalised data was then carried out using PathVisio and WikiPathways. Commonly altered 
genes in different cell models were also analysed by gene ontology using Cytoscape and 
ClueGO. 
 
Supplemental Figure 2. Common altered pathways in 1,25(OH)2D-treated THP-1, DCs, 
monocytes and B cells. Heat map representing Z-scores for pathways significantly altered 
by 1,25(OH)2D after performing a pathway analysis on datasets from immune cells treated 
with 1,25(OH)2D. Z-scores >1.96 indicate that more genes are significantly altered in this 
pathway compared to the complete dataset.  
 
Supplemental Figure 3. ClueGO analysis represented as networks in Cytoscape. 
Nodes representing GO biological processes are displayed in three differentiated networks 
named as the biological processes that are overrepresented: bioenergetic (showed in figure 
3) immune processes (A) and apoptosis (B). The colours represent the GO group, each 
node is a biologic process and the edges shows the connectivity between each node based 
on the connection of the genes that contain. Nodes with no connections are coloured in grey. 
 
Supplemental Figure 4. Effect of 1,25(OH)2D on genes associated with glycolysis and 
gluconeogenesis. Visualization of changes in gene expression after 1,25(OH)2D treatment 
in THP-1 cells, DCs and monocytes. Log2 fold changes are shown as a gradient from blue 
(downregulated) to red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are 
shown in green. 
 
Supplemental Figure 5. Effect of 1,25(OH)2D on genes associated with G1 to S cell 
cycle control (A) and Retinoblastoma in Cancer (B). WikiPathways representation of A) 
G1 to S cell cycle control; B) Retinoblastoma in Cancer pathways identified by Pathvisio 
using gene expression data from THP-1 cells treated with 1,25(OH)2D. Log2 fold changes 
are shown as a gradient from blue (downregulated) to red (upregulated) over white 
(unchanged). Adjusted p-values < 0.05 are shown in green. 
 
Supplemental Figure 6. Effect of 1,25(OH)2D on genes associated with apoptosis (A) 
and apoptosis modulation by HSP70 (B). WikiPathways representation of A) apoptosis; B) 
apoptosis modulation by HSP70. Visualization of changes in gene expression after 
1,25(OH)2D treatment in THP-1 cells, DCs and monocytes. Log2 fold changes are shown as 
a gradient from blue (downregulated) to red (upregulated) over white (unchanged). Adjusted 
p-values < 0.05 are shown in green. 
 
Supplemental Figure 7.  Temporal effect of 1,25(OH)2D treatment in THP-1 cells.  To 
evaluate temporal effects of 1,25(OH)2D comparison of pathway analysis was carried out for  
THP-1 cell array analyses at 24 hours (Nurminem et al (GSE60102)), and 4 hours 
(Heikkinen et al (GSE27270)) and an RNA-seq study where THP-1 cells were treated with 
1,25(OH)2D for 2.5, 4 and 24 hours (Seuter et al. (GSE36323)).  Electron transport chain, 
oxidative phosphorylation and TCA cycle are only significantly altered (Z>1.96) in THP-1 
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cells treated with 1,25(OH)2D  for 24 hours. Furthermore, cell cycle pathways related are 
only significantly altered (Z>1.96) in THP-1 cells of 1,25(OH)2D 24 hours treatment cells from 
Nurminem and Vermay datasets. 
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Legends to figures and tables 
 
Figure 1. Common altered pathways in 1,25(OH)2D-treated THP-1, DCs and 
monocytes. Heat map representing Z-scores for pathways significantly altered by 
1,25(OH)2D after performing a pathway analysis on datasets for THP-1, DCs and monocytes 
treated with 1,25(OH)2D. Z-scores >1.96 indicate that more genes are significantly altered in 
this pathway compared to the complete dataset.  
 
Figure 2. 1,25(OH)2D-regulated genes in THP-1 cells, DCs and monocytes. Venn 
diagrams showing numbers of common and cell-specific genes regulated by 1,25(OH)2D in 
THP-1 cells, DCs and monocytes. Genes with an absolute log2 fold change > 0.26 and 
adjusted p-value < 0.05 were considered as regulated. 
 
Figure 3. ClueGO Gene ontology analysis of common 1,25(OH)2D-regulated 
bioenergetics genes in THP-1 cells, DCs and monocytes. Cytoscape analysis showing 
overrepresented bioenergetic pathways for 1,25(OH)2D-treated THP-1 cells, DCs and 
monocytes. Colours represent the GO group, each node is a GO biological process and the 
edges shows the connectivity between each node based on the connection of the genes that 
contain. The size of the nodes depends on the amount of genes that are grouped. Nodes 
with no connections are coloured in grey. 
 
Figure 4. Effect of 1,25(OH)2D on genes associated with the electron transport chain. 
Visualization of changes in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs 
and monocytes. Log2 fold changes are shown as a gradient from blue (downregulated) to 
red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are shown in green. 
 
Figure 5. Effect of 1,25(OH)2D on genes associated with oxidative phosphorylation. 
Visualization of changes in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs 
and monocytes. Log2 fold changes are shown as a gradient from blue (downregulated) to 
red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are shown in green. 
 
Figure 6. Effect of 1,25(OH)2D on genes associated with the TCA cycle. Visualization of 
changes in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs and monocytes. 
Log2 fold changes are shown as a gradient from blue (downregulated) to red (upregulated) 
over white (unchanged). Adjusted p-values < 0.05 are shown in green. 
 
Figure 7. Effect of 1,25(OH)2D on the expression of genes associated with cell 
proliferation in THP-1 cells. WikiPathways representation of A) cell cycle; B) DNA 
replication pathways. Visualization of changes in gene expression after 1,25(OH)2D 
treatment in THP-1 cells. Log2 fold changes are shown as a gradient from blue 
(downregulated) to red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are 
shown in green. 
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Supplemental Figure 1. Overview of the analytical tools included in the workflow. Raw 
data were normalised and statistically analysed using ArrayAnalysis. Pathway analysis of 
normalised data was then carried out using PathVisio and WikiPathways. Commonly altered 
genes in different cell models were also analysed by gene ontology using Cytoscape and 
ClueGO. 
 
Supplemental Figure 2. Common altered pathways in 1,25(OH)2D-treated THP-1, DCs, 
monocytes and B cells. Heat map representing Z-scores for pathways significantly altered 
by 1,25(OH)2D after performing a pathway analysis on datasets from immune cells treated 
with 1,25(OH)2D. Z-scores >1.96 indicate that more genes are significantly altered in this 
pathway compared to the complete dataset.  
 
Supplemental Figure 3. ClueGO analysis represented as networks in Cytoscape. 
Nodes representing GO biological processes are displayed in three differentiated networks 
named as the biological processes that are overrepresented: bioenergetic (showed in figure 
3) immune processes (A) and apoptosis (B). The colours represent the GO group, each 
node is a biologic process and the edges shows the connectivity between each node based 
on the connection of the genes that contain. Nodes with no connections are coloured in grey. 
 
Supplemental Figure 4. Effect of 1,25(OH)2D on genes associated with glycolysis and 
gluconeogenesis. Visualization of changes in gene expression after 1,25(OH)2D treatment 
in THP-1 cells, DCs and monocytes. Log2 fold changes are shown as a gradient from blue 
(downregulated) to red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are 
shown in green. 
 
Supplemental Figure 5. Effect of 1,25(OH)2D on genes associated with G1 to S cell 
cycle control (A) and Retinoblastoma in Cancer (B). WikiPathways representation of A) 
G1 to S cell cycle control; B) Retinoblastoma in Cancer pathways identified by Pathvisio 
using gene expression data from THP-1 cells treated with 1,25(OH)2D. Log2 fold changes 
are shown as a gradient from blue (downregulated) to red (upregulated) over white 
(unchanged). Adjusted p-values < 0.05 are shown in green. 
 
Supplemental Figure 6. Effect of 1,25(OH)2D on genes associated with apoptosis (A) 
and apoptosis modulation by HSP70 (B). WikiPathways representation of A) apoptosis; B) 
apoptosis modulation by HSP70. Visualization of changes in gene expression after 
1,25(OH)2D treatment in THP-1 cells, DCs and monocytes. Log2 fold changes are shown as 
a gradient from blue (downregulated) to red (upregulated) over white (unchanged). Adjusted 
p-values < 0.05 are shown in green. 
 
Supplemental Figure 7.  Temporal effect of 1,25(OH)2D treatment in THP-1 cells.  To 
evaluate temporal effects of 1,25(OH)2D comparison of pathway analysis was carried out for  
THP-1 cell array analyses at 24 hours (Nurminem et al (GSE60102)), and 4 hours 
(Heikkinen et al (GSE27270)) and an RNA-seq study where THP-1 cells were treated with 
1,25(OH)2D for 2.5, 4 and 24 hours (Seuter et al. (GSE36323)).  Electron transport chain, 
oxidative phosphorylation and TCA cycle are only significantly altered (Z>1.96) in THP-1 
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cells treated with 1,25(OH)2D  for 24 hours. Furthermore, cell cycle pathways related are 
only significantly altered (Z>1.96) in THP-1 cells of 1,25(OH)2D 24 hours treatment cells from 
Nurminem and Vermay datasets. 
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Figure 1. Common altered pathways in 1,25(OH)2D-treated THP-1, DCs and monocytes. Heat map 
representing Z-scores for pathways significantly altered by 1,25(OH)2D after performing a pathway analysis 
on datasets for THP-1, DCs and monocytes treated with 1,25(OH)2D. Z-scores >1.96 indicate that more 
genes are significantly altered in this pathway compared to the complete dataset.  
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Figure 2. 1,25(OH)2D-regulated genes in THP-1 cells, DCs and monocytes. Venn diagrams showing numbers 
of common and cell-specific genes regulated by 1,25(OH)2D in THP-1 cells, DCs and monocytes. Genes with 
an absolute log2 fold change > 0.26 and adjusted p-value < 0.05 were considered as regulated.  
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Figure 3. ClueGO Gene ontology analysis of common 1,25(OH)2D-regulated bioenergetics genes in THP-1 
cells, DCs and monocytes. Cytoscape analysis showing overrepresented bioenergetic pathways for 
1,25(OH)2D-treated THP-1 cells, DCs and monocytes. Colours represent the GO group, each node is a GO 
biological process and the edges shows the connectivity between each node based on the connection of the 
genes that contain. The size of the nodes depends on the amount of genes that are grouped. Nodes with no 
connections are coloured in grey.  
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Figure 4. Effect of 1,25(OH)2D on genes associated with the electron transport chain. Visualization of 
changes in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs and monocytes. Log2 fold 
changes are shown as a gradient from blue (downregulated) to red (upregulated) over white (unchanged). 
Adjusted p-values < 0.05 are shown in green.  
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Figure 5. Effect of 1,25(OH)2D on genes associated with oxidative phosphorylation. Visualization of changes 
in gene expression after 1,25(OH)2D treatment in THP-1 cells, DCs and monocytes. Log2 fold changes are 
shown as a gradient from blue (downregulated) to red (upregulated) over white (unchanged). Adjusted p-
values < 0.05 are shown in green.  
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Figure 6. Effect of 1,25(OH)2D on genes associated with the TCA cycle. Visualization of changes in gene 
expression after 1,25(OH)2D treatment in THP-1 cells, DCs and monocytes. Log2 fold changes are shown as 
a gradient from blue (downregulated) to red (upregulated) over white (unchanged). Adjusted p-values < 
0.05 are shown in green.  
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Figure 7. Effect of 1,25(OH)2D on the expression of genes associated with cell proliferation in THP-1 cells. 
WikiPathways representation of A) cell cycle; B) DNA replication pathways. Visualization of changes in gene 
expression after 1,25(OH)2D treatment in THP-1 cells. Log2 fold changes are shown as a gradient from blue 
(downregulated) to red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are shown in 
green.  
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Figure 7. Effect of 1,25(OH)2D on the expression of genes associated with cell proliferation in THP-1 cells. 
WikiPathways representation of A) cell cycle; B) DNA replication pathways. Visualization of changes in gene 
expression after 1,25(OH)2D treatment in THP-1 cells. Log2 fold changes are shown as a gradient from blue 
(downregulated) to red (upregulated) over white (unchanged). Adjusted p-values < 0.05 are shown in 
green.  
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Table 1. Regulation of gene expression by 1,25(OH)2D in THP-1, dendritic cells and 
monocyte models. Total number of genes measured for each gene expression repository 
and the number of genes with significantly altered expression. Genes with an absolute log 
fold change > 0.26 and adjusted p-value < 0.05 were considered as regulated. Based on the 
expression parameter log fold change genes are classified by up-regulated (log fold-change 
> 0.26) and down-regulated (log fold-change <-0.26).  
 
 
Dataset Type of cell Genes measured Genes significantly 
altered 
Genes up-regulated Genes down-regulated 
Verway M et al. (2013) THP-1 21,664 2,652 1,194 1,458 
Széles L et al. (2009) Immature DC 20,111 2,093 1,130 963 
Ferreira G et al (2014) Monocytes 21,664 1,248 525 723 
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